Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

50.0%

2 terminated/withdrawn out of 4 trials

Success Rate

33.3%

-53.2% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Early Phase 1
1(100.0%)
1Total
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04338503Unknown

Mechanically Optimizing Cardiac Preload in Heart Failure Patients

Role: collaborator

NCT02169622Completed

CABG REVEAL: Atrial Fibrillation After Coronary Artery Bypass Graft

Role: lead

NCT00713921Early Phase 1Withdrawn

Neuropathic Investigation and Anticholinergic Treatment of Bladder Dysfunction in Diabetes and Stroke Patients

Role: lead

NCT03257683Withdrawn

RANOLAZINE STUDY: Speckle Tracking Derived Myocardial Strain

Role: lead

All 4 trials loaded